SCHEMBL21153649

SCHEMBL21153649

CCCC1O[C@@H]2CC3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@]2(C(=O)COC(=O)N(C)CCS)O1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 10/20 0.74
▸ PGR P06401 7/20 0.74
▸ HIF1A Q16665 4/20 0.74
▸ CYP3A4 P08684 3/20 0.74
▸ LMNA P02545 2/20 0.74
▸ ABCC3 O15438 1/20 0.74
▸ ABCC4 O15439 1/20 0.74
▸ ABCB11 O95342 1/20 0.74
▸ IL5 P05113 1/20 0.74
▸ NR3C2 P08235 1/20 0.74
▸ AR P10275 1/20 0.74
▸ CHRM1 P11229 1/20 0.74
▸ MMP9 P14780 1/20 0.74
▸ NFKB1 P19838 1/20 0.74
▸ THPO P40225 1/20 0.74
▸ SMN1; SMN2 Q16637 1/20 0.74
▸ HSD17B10 Q99714 1/20 0.74
▸ BLM P54132 1/20 0.74
▸ PMP22 Q01453 1/20 0.74
▸ NPSR1 Q6W5P4 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21152548 1.00 NR3C1 (0.74) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL21152812 0.96 NR3C1 (0.74) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL22210733 0.94 NR3C1 (0.73) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL20226801 0.93 NR3C1 (0.71) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL21152784 0.93 NR3C1 (0.71) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL22961047 0.93 NR3C1 (0.71) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL21569935 0.93 NR3C1 (0.71) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL4445954 0.90 NR3C1 (0.75) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL13816837 0.90 NR3C1 (0.74) NR3C1PGRHIF1ACYP3A4LMNA
SCHEMBL14001451 0.90 NR3C1 (0.74) NR3C1PGRHIF1ACYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019217591-A1 ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-11-14 — — WO disclosed
WO-2019136487-A2 STEROIDS AND ANTIBODY-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-07-11 — — WO disclosed
Send feedback